Showing results (141-150 of 250) with videos related to

Sort By:
Pageof 25
Blood Advances|May 31, 2024
Safety and efficacy of luspatercept for the treatment of anemia in patients with myelofibrosisAaron T Gerds, Claire Harrison, Jean-Jacques Kiladjian, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 2, 2017
Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in OncologyPeter L Greenberg, Richard M Stone, Aref Al-Kali, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2004
Acute monocytic leukemia (French-American-British classification M5) does not have a worse prognosis than other subtypes of acute myeloid leukemia: a report from the Eastern Cooperative Oncology GroupMartin S Tallman, Haesook T Kim, Elisabeth Paietta, et al.
Leukemia Research|February 12, 2025
Characteristics and survival outcomes of patients with myelodysplastic syndromes with isolated 11q deletionKensuke Takaoka, Rami Komrokji, Kelly Chien, et al.
Leukemia Research|May 4, 2007
Therapy-related myelodysplastic syndrome and acute myeloid leukemia following initial treatment with chemotherapy plus radioimmunotherapy for indolent non-Hodgkin lymphomaGail J Roboz, John M Bennett, Morton Coleman, et al.
Leukemia Research|September 6, 2011
Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: Case series and literature reviewMichael J Rauh, Fazlur Rahman, David Good, et al.
Transfusion|November 24, 2016
Wide variations in blood product transfusion practices among providers who care for patients with acute leukemia in the United StatesAlexander B Pine, Eun-Ju Lee, Mikkael Sekeres, et al.
BMC Cancer|August 20, 2016
Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort studyDavid P Steensma, Medrdad Abedi, Rafael Bejar, et al.
British Journal of Haematology|December 12, 2023
TP53 variant allele frequency and therapy-related setting independently predict survival in myelodysplastic syndromes with del(5q)Ayalew Tefferi, Farah Fleti, Onyee Chan, et al.
Leukemia Research|December 7, 2007
Common troublesome symptoms and their impact on quality of life in patients with myelodysplastic syndromes (MDS): results of a large internet-based surveyDavid P Steensma, Kathleen V Heptinstall, Victor M Johnson, et al.
Pageof 25